Universe Pharmaceuticals (UPC) Retained Earnings: 2020-2024
- Universe Pharmaceuticals' Retained Earnings fell 328.77% to -$10.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$10.2 million, marking a year-over-year decrease of 328.77%. This contributed to the annual value of -$10.2 million for FY2024, which is 328.77% down from last year.
- Per Universe Pharmaceuticals' latest filing, its Retained Earnings stood at -$10.2 million for Q3 2024, which was down 245.72% from -$2.9 million recorded in Q1 2024.
- Universe Pharmaceuticals' Retained Earnings' 5-year high stood at $13,739.0 billion during Q3 2020, with a 5-year trough of -$10.2 million in Q3 2024.
- In the last 3 years, Universe Pharmaceuticals' Retained Earnings had a median value of $6.6 million in 2023 and averaged $7.2 million.
- Data for Universe Pharmaceuticals' Retained Earnings shows a maximum YoY slumped of 328.77% (in 2024) over the last 5 years.
- Over the past 5 years, Universe Pharmaceuticals' Retained Earnings (Quarterly) stood at $13,739.0 billion in 2020, then plummeted by 100.00% to $25.1 million in 2021, then plummeted by 34.86% to $16.3 million in 2022, then tumbled by 114.53% to -$2.4 million in 2023, then plummeted by 328.77% to -$10.2 million in 2024.
- Its Retained Earnings stands at -$10.2 million for Q3 2024, versus -$2.9 million for Q1 2024 and -$2.4 million for Q3 2023.
